NeuroSense Therapeutics Ltd.
NRSN
$0.83
-$0.02-2.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.13M | -7.92M | -- | -- | -- |
| Total Depreciation and Amortization | 16.00K | 12.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.09M | 1.20M | -- | -- | -- |
| Change in Net Operating Assets | 1.34M | 869.50K | -- | -- | -- |
| Cash from Operations | -7.67M | -5.84M | -- | -- | -- |
| Capital Expenditure | -8.00K | -6.50K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -4.00K | -- | -- | -- |
| Cash from Investing | -8.00K | -10.50K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.55M | 2.96M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -121.00K | -93.00K | -- | -- | -- |
| Cash from Financing | 4.43M | 2.87M | -- | -- | -- |
| Foreign Exchange rate Adjustments | 35.00K | 17.50K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.21M | -2.96M | -- | -- | -- |